1-11 of 11
Steve T Rosen
Close
Sort by
Journal Articles

Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

Swetha Kambhampati, Matthew Mei, Lu Chen, Sandrine Puverel, Robert Chen, Leslie L. Popplewell, Liana Nikolaenko, Lacolle Peters, Saro H. Armenian, Larry W. Kwak, Steve T Rosen, Stephen J Forman, Alex F. Herrera
Journal: Blood
Blood (2022) 140 (Supplement 1): 9418–9419.
https://doi.org/10.1182/blood-2022-157623
Published: 2022
Journal Articles

Receptor Targeted Delivery of the p38γ Inhibitor PIK-75 By Organic-Core Templated Lipid Nanoparticles in Cutaneous T Cell Lymphoma

Jonathan Scott Rink, Stephen E. Henrich, Alexandra Moxley, Xu Hannah Zhang, Xiwei Wu, SonBinh Nguyen, Christiane Querfeld, David A. Horne, Steve T. Rosen, Leo I. Gordon, Colby Shad Thaxton, Adam Yuh Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 4934–4935.
https://doi.org/10.1182/blood-2022-158864
Published: 2022
Journal Articles

Targeting the Methionine-MAT2A-SAM Axis of Acute Myeloid Leukemia with a Combination of Venetoclax and 8-Chloro-Adenosine or 8-Amino-Adenosine

Jiamin Guo, Ralf Buettner, Li Du, Yanzhong Yang, Zhenlong Li, Steve T Rosen
Journal: Blood
Blood (2022) 140 (Supplement 1): 3056–3057.
https://doi.org/10.1182/blood-2022-167606
Published: 2022
Journal Articles

Blockade of the Immune Checkpoint CD47 By TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T Cell Lymphoma

Zhen Han, Xiwei Wu, Yate-Ching Yuan, Hanjun Qin, Chingyu Su, Jasmine Zain, Oleg E Akilov, Steve T Rosen, Mingye Feng, Christiane Querfeld
Journal: Blood
Blood (2022) 140 (Supplement 1): 6376–6377.
https://doi.org/10.1182/blood-2022-167670
Published: 2022
Journal Articles

Sumoylation Inhibition Potentiates Daratumumab Activity Against Multiple Myeloma

Li Du, Wei Liu, Enrico Caserta, Flavia Pichiorri, Steve T Rosen
Journal: Blood
Blood (2022) 140 (Supplement 1): 9972–9973.
https://doi.org/10.1182/blood-2022-158040
Published: 2022
Journal Articles

TET2-Mediated mRNA and DNA Oxidation in Leukemia Homing and Immune Evasion

Yangchan Li, Xiaolan Deng, Lei Dong, Li Han, Le Xuan Truong Nguyen, Jianhuang Xue, Zhicong Zhao, Wei Li, Ying Qing, Chao Shen, Brandon Tan, Zhenhua Chen, Meilin Xue, Keith Leung, Kitty Wang, Srividya Swaminathan, Ling Li, Mark Wunderlich, James C Mulloy, Bin Zhang, David A Horne, Steve T Rosen, Guido Marcucci, Mingjiang Xu, Zejuan Li, Minjie Wei, Rui Su, Jianjun Chen
Journal: Blood
Blood (2022) 140 (Supplement 1): 2975–2977.
https://doi.org/10.1182/blood-2022-162619
Published: 2022
Journal Articles

Disrupting MGA-MYC Driven Metabolic Reprogramming in Richter's Syndrome Pre-Clinical Models Via Novel Therapeutic Approaches

Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Hart, Joo Y. Song, Wing C Chan, Tanya Siddiqi, Alexey V Danilov, Steve T Rosen, Lili Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9842–9843.
https://doi.org/10.1182/blood-2022-162664
Published: 2022
Journal Articles

Synergy Of Small-Molecule Inhibitors In Cutaneous T-Cell Lymphoma Cells: A Discovery Tool To Define New Therapeutic Targets In T-Cell Receptor (TCR) Signaling Pathways

Meghan Bliss-Moreau, Cristian Coarfa, Weimin Xiao, Preethi Gunaratne, Nancy L Krett, PhD, Steve T. Rosen, MD
Journal: Blood
Blood (2013) 122 (21): 4327.
https://doi.org/10.1182/blood.V122.21.4327.4327
Published: 2013
Journal Articles

Long-Term Remission After Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T Cell Lymphoma

John P. Galvin, MD, MPH, Joanne Monreal, Joan Guitart, MD, Steve T. Rosen, MD, Timothy Kuzel, MD, Jayesh Mehta, MD
Journal: Blood
Blood (2012) 120 (21): 2028.
https://doi.org/10.1182/blood.V120.21.2028.2028
Published: 2012
Journal Articles

A Phase II Trial of Combination Bortezomib (Velcade®) and Rituximab for Untreated “High Tumor Burden” Indolent Non-Hodgkin Lymphoma (NHL).

Kevin A. David, MD, Mitchell R. Smith, MD, PhD, Izidore S. Lossos, MD, Eren Roubal, BS, Jane N. Winter, MD, Steve T. Rosen, MD, Leo I. Gordon, MD, Andrew M. Evens, DO, MS
Journal: Blood
Blood (2008) 112 (11): 2004.
https://doi.org/10.1182/blood.V112.11.2004.2004
Published: 2008
Journal Articles

Effects of A771726, the Active Metabolite of Leflunomide,on Multiple Myeloma Cells Proliferation in Vitro .

Shaosong Yang, Ph.D., Girish Venkataraman, M.D., Nancy L. Krett, Ph.D., Steve T. Rosen, M.D.
Journal: Blood
Blood (2004) 104 (11): 4893.
https://doi.org/10.1182/blood.V104.11.4893.4893
Published: 2004